Skip to main content
Beat Cancer EU Website Logo
TreatmentMedical Term

Allogeneic Stem Cell Transplant

Definition

An allogeneic stem cell transplant is a medical procedure where a patient receives blood-forming stem cells from a genetically similar, but not identical, donor. This treatment is often used for conditions affecting the bone marrow or blood, such as leukemia and lymphoma.

What is an Allogeneic Stem Cell Transplant and How to Use It in Treatment

<a href=allogeneic stem cell transplant" class="featured-image" />

Overview

An allogeneic stem cell transplant involves transferring stem cells from a donor to a patient. These stem cells can develop into different types of blood cells, helping to replace damaged or diseased bone marrow. This procedure is crucial for treating certain cancers and blood disorders.

Key Information

Allogeneic stem cell transplants are typically used when a patient's bone marrow is not functioning properly due to disease, chemotherapy, or radiation. The donor is often a sibling or unrelated individual with a compatible tissue type. Matching is done based on human leukocyte antigen (HLA) markers.

Clinical Significance

This type of transplant is significant in treating leukemia, lymphoma, and other blood-related disorders. It can restore the bone marrow's ability to produce healthy blood cells and may provide a new immune system to fight cancer cells.

Treatment & Management

The process involves several steps, including finding a suitable donor, collecting stem cells, conditioning therapy, and transplanting the cells into the patient. Post-transplant, patients are monitored for complications such as graft-versus-host disease (GVHD), where the donor cells attack the patient's body.

Patient Resources

Patients can access resources through hospitals, cancer centers, and organizations like the American Cancer Society. Support groups and educational materials are available to help patients and families understand the process and manage side effects.

Frequently Asked Questions

  • What are the risks of an allogeneic stem cell transplant?

Risks include infection, GVHD, and organ damage. Close monitoring and medications help manage these risks.

  • How long is the recovery period?

Recovery can take several months to a year, depending on individual health and complications.

  • Who can be a donor?

Donors are usually siblings or unrelated individuals with matching HLA markers. Registries like Be The Match help find donors.

Discussion & Questions

Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.

Leave a Comment

Minimum 10 characters, maximum 2000 characters

No comments yet

Be the first to share your thoughts!

Related Terms

Irinotecan

A Comprehensive Overview of Irinotecan: An Essential Drug in Healthcare

Irinotecan is a type of chemotherapy drug, classified as a topoisomerase I inhibitor. This drug is used primarily in the treatment of cancers, including colorectal and lung cancer. It works by interfering with the replication of cancerous cells, thereby preventing their growth and spread. Irinotecan is commonly administered intravenously.

Read more

Adjuvant chemotherapy

Adjuvant chemotherapy: what you need to know

Adjuvant chemotherapy is a treatment approach using drugs to kill cancer cells left in the body after primary treatments, such as surgery or radiation. This method is typically employed to lower the risk of cancer recurrence and improve the patient's overall survival rate.

Read more

Anti-emetic refers to a type of medication used primarily to prevent or treat nausea and vomiting, symptoms often associated with motion sickness, chemotherapy, radiation, and surgery. Such drugs work by blocking neurotransmitters that trigger these unpleasant sensations. Thus, they are critical in the management of postoperative and chemotherapy-induced nausea and vomiting.

Read more